» Authors » Masamichi Imai

Masamichi Imai

Explore the profile of Masamichi Imai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 199
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Satoh Y, Hanaoka K, Ikegawa C, Imai M, Watanabe S, Morimoto-Ishikawa D, et al.
Diagnostics (Basel) . 2023 Mar; 13(6). PMID: 36980385
The performances of photomultiplier tube (PMT)-based dedicated breast positron emission tomography (PET) and silicon photomultiplier tube (SiPM)-based time-of-flight (TOF) PET, which is applicable not only to breast imaging but also...
2.
Satoh Y, Imai M, Ikegawa C, Hirata K, Abo N, Kusuzaki M, et al.
Ann Nucl Med . 2022 Oct; 36(12):1010-1018. PMID: 36207497
Objective: Semi-quantitative positron emission tomography (PET) values, such as the maximum standardized uptake value (SUV), are widely used to identify malignant lesions and evaluate the response to treatment. The image...
3.
Satoh Y, Imai M, Ikegawa C, Onishi H
Jpn J Radiol . 2022 May; 40(11):1186-1193. PMID: 35612727
Purpose: To evaluate the clinical feasibility of high-resolution dedicated breast positron emission tomography (dbPET) with real low-dose F-2-fluorodeoxy-D-glucose (F-FDG) by comparing images acquired with full-dose FDG. Materials And Methods: Nine...
4.
Toyohara J, Sakata M, Ishibashi K, Mossel P, Imai M, Wagatsuma K, et al.
Ann Nucl Med . 2021 Aug; 35(11):1240-1252. PMID: 34368924
Objective: 5-(1-(2-[F]fluoroethoxy))-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-propyl]-5,6,7,8-tetrahydronaphthalen ([F]MC225) is a selective substrate for P-glycoprotein (P-gp), possessing suitable properties for measuring overexpression of P-gp in the brain. This is the first-in-human study to examine safety, radiation...
5.
Satoh Y, Imai M, Hirata K, Asakawa Y, Ikegawa C, Onishi H
Ann Nucl Med . 2021 Mar; 35(5):608-616. PMID: 33772738
Objective: This study aimed to determine the optimal β value of the relaxation control parameter and the post-smoothing filter in the list-mode dynamic row-action maximum likelihood algorithm (LM-DRAMA) to detect...
6.
Satoh Y, Motosugi U, Imai M, Omiya Y, Onishi H
EJNMMI Phys . 2021 Jan; 8(1):5. PMID: 33462645
Background: Using phantoms and clinical studies in prone hanging breast imaging, we assessed the image quality of a commercially available dedicated breast PET (dbPET) at the detector's edge, where mammary...
7.
Imai M, Kosaka Y, Tachi M, Mori K, Maruno H
Clin Nucl Med . 2020 Oct; 45(12):999-1000. PMID: 33086269
We present a novel report on the use of bone scintigraphy in pembrolizumab-induced inflammatory arthritis. A 70-year-old man with lung cancer complained about arthralgia after 7 courses of the pembrolizumab...
8.
de Vasconcellos H, Win T, Chamera E, Hong S, Ambale Venkatesh B, Young P, et al.
Acad Radiol . 2020 Apr; 28(3):356-363. PMID: 32279912
Rationale And Objectives: Left Atrial (LA) adverse remodeling is an important predictor of morbidity and mortality in several cardiovascular (CV) diseases. Our goals were to quantify and provide reference ranges...
9.
Imai M, Tanaka M, Sakata M, Wagatsuma K, Tago T, Toyohara J, et al.
J Alzheimers Dis . 2019 Nov; 73(1):197-207. PMID: 31771066
Background: Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are often misdiagnosed with each other because of similar symptoms including progressive memory loss. The metabolic network topology that describes...
10.
Satoh Y, Motosugi U, Imai M, Onishi H
Ann Nucl Med . 2019 Nov; 34(2):119-127. PMID: 31768819
Objective: High-resolution dedicated breast positron emission tomography (dbPET) can visualize breast cancer more clearly than whole-body PET/computed tomography (CT). In Japan, the combined use of dbPET and whole-body PET/CT is...